Press release
Mastitis Market Trends & Forecast to 2034
The Mastitis Market is expanding steadily due to rising mastitis prevalence in dairy cattle, increased livestock healthcare spending, and growing adoption of advanced diagnostic and therapeutic solutions. As dairy productivity becomes a global priority, demand for mastitis treatment, prevention products, and rapid diagnostics continues to grow. Below is a full breakdown including key players, segmentation, industry updates, and growth drivers.Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/51962
1. What Is Mastitis? (Keyword Definition)
Mastitis is an inflammatory disease of the mammary gland, primarily affecting dairy cattle, goats, and sheep. It is caused by:
• Bacterial infections (Staphylococcus, Streptococcus, E. coli)
• Udder injury
• Poor milking hygiene
• Environmental contamination
Symptoms include udder swelling, reduced milk production, fever, and abnormalities in milk consistency. Mastitis leads to major economic losses due to reduced yield, discarded milk, medical costs, and decreased animal welfare.
2. Key Players in the Market
Top companies providing mastitis treatment, diagnostics, and prevention solutions include:
• Zoetis Inc.
• Boehringer Ingelheim
• Elanco Animal Health
• Ceva Santé Animale
• Bayer Animal Health
• DeLaval
• Vetoquinol SA
• Merck Animal Health (MSD)
• HIPRA
• Neogen Corporation
These companies invest heavily in antibiotics, vaccines, teat sealants, dairy hygiene solutions, and rapid diagnostic kits.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/51962/mastitis-market
3. Key Events in the Last 5 Years
Major developments influencing the mastitis market include:
• Increased mastitis screening programs across Europe, North America, and New Zealand.
• Development of rapid PCR and on-farm testing kits for early pathogen detection.
• Growing focus on antibiotic stewardship, leading to innovations in selective dry cow therapy.
• Rising adoption of mastitis vaccines as preventive strategies.
• Expansion of dairy automation, such as robotic milking systems, reducing infection risk.
• Government-funded livestock health programs in India, China, and African nations.
• Growing concerns around antimicrobial resistance (AMR), influencing treatment protocols.
4. Market Growth Rate (CAGR & Forecast)
The Mastitis Market is projected to grow at a CAGR of 5%-7% from 2024 to 2034.
Growth factors include:
• Rising global milk consumption
• Increased commercial dairy herd sizes
• Adoption of advanced detection technologies
• Government support for livestock health and productivity
• Growing awareness of animal welfare and farm hygiene
By 2034, the market is expected to achieve a multi-billion-dollar valuation.
5. Market Segments & Growth Analysis
By Type of Mastitis
• Clinical Mastitis - Visible symptoms; requires immediate treatment.
• Subclinical Mastitis - Most common; detected through SCC tests and diagnostics.
By Treatment Type
• Antibiotics - Penicillin, cephalosporins, and macrolides.
• Anti-inflammatory Agents - NSAIDs for pain and swelling control.
• Intramammary Infusions - Most widely used treatment method.
• Supportive Therapy - Fluids, vitamins, and udder care products.
• Vaccines - Increasing adoption for prevention.
By Diagnostic Method
• Somatic Cell Count (SCC) - Standard screening tool.
• Culture Tests - Identifies causative bacteria.
• PCR Testing - Rapid pathogen identification.
• On-Farm Kits - California Mastitis Test (CMT), rapid strips.
• Automated Milking System Sensors - Emerging real-time detection technology.
By Product Category
• Teat Sealants - Key preventive solution.
• Disinfectants & Udder Hygiene Products - High consumption in commercial farms.
• Intramammary Antibiotics - Largest product segment.
• Vaccines - Growing due to reduced antibiotic reliance.
By End User
• Dairy Farms - Largest consumer base.
• Veterinary Clinics - Manage treatment protocols.
• Animal Health Research Centers - Developing new vaccines and diagnostics.
• Milk Cooperatives - Invest in herd health improvement programs.
By Region
• North America - Strong dairy infrastructure and diagnostic adoption.
• Europe - Highest regulatory focus on antibiotic control.
• Asia-Pacific - Fastest growth due to expanding dairy sector.
• Latin America & MEA - Increasing commercialization of dairy farming.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=51962
6. Key Market Drivers
• Rising dairy product demand, pushing farms to improve milk yield.
• Growing mastitis awareness and control programs in developing regions.
• Increased adoption of milking automation reducing contamination risks.
• Technological advancements in on-farm diagnostics enabling early detection.
• Shift toward preventive care, including vaccines and teat sealants.
• Focus on reducing antibiotic use due to AMR concerns.
• Expansion of commercial dairy farms, especially in India and China.
7. Conclusion
The Mastitis Market is positioned for steady long-term growth as dairy industries worldwide adopt better prevention, detection, and treatment strategies. With advancements in veterinary diagnostics, modernization of dairy operations, and awareness about animal health, the sector is set for continued expansion through 2034. Innovations in vaccines, automation, and rapid diagnostics will further improve disease control and enhance dairy productivity globally.
This report is also available in the following languages : Japanese (乳腺炎市場), Korean (유방염 시장), Chinese (乳腺炎市场), French (Marché de la mastite), German (Mastitis-Markt), and Italian (Mercato della mastite), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/reports/51962/mastitis-market#request-a-sample
Our More Reports:
Alpha Glucosidase Inhibitors Market
https://exactitudeconsultancy.com/reports/51927/alpha-glucosidase-inhibitors-market
Antacid Market
https://exactitudeconsultancy.com/reports/51929/antacid-market
Breakthrough Therapy Designation Market
https://exactitudeconsultancy.com/reports/51932/breakthrough-therapy-designation-market
Dendritic Cell Cancer Vaccine Market
https://exactitudeconsultancy.com/reports/73168/dendritic-cell-cancer-vaccines-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mastitis Market Trends & Forecast to 2034 here
News-ID: 4275570 • Views: …
More Releases from Exactitude Consultancy
Mucormycosis Market Key Players, Treatments & Forecast to 2034
Mucormycosis Market Expands as Fungal Infections Rise in Immunocompromised Populations - Key Players, Treatments & Forecast to 2034
The Mucormycosis Market has gained global attention due to the rise in invasive fungal infections, particularly among diabetic, immunocompromised, and post-COVID patient populations. Increased hospitalization rates, improved diagnostic tools, and the urgent need for fast-acting antifungal therapies are pushing market growth through 2034. Below is a complete breakdown of key players, developments,…
Moebius Syndrome Market Developments & Forecast to 2034
The Moebius Syndrome Market is gaining global attention as awareness improves around this rare neurological condition characterized by facial paralysis and impaired eye movement. With increasing diagnostic capabilities, multidisciplinary care adoption, and supportive therapy innovations, the market is expected to grow steadily through 2034. Below is a complete overview covering key players, segmentation, clinical trends, and major growth drivers.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/51964
1. What Is Moebius…
Retinal Vein Occlusion Market Trends & Forecast to 2034
The Retinal Vein Occlusion Market is expanding steadily as ophthalmology adopts advanced imaging, anti-VEGF injections, and laser therapies for managing this vision-threatening disorder. Rising diabetic and hypertensive populations, growing screening programs, and increased clinical trials for long-acting biologics are fueling market momentum through 2034. Here is a complete market breakdown covering key players, segmentation, events, and growth drivers.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72291
1. What Is Retinal Vein…
Anaplasmosis Treatment Market Therapeutic Advances & Forecast to 2034
The Anaplasmosis Treatment Market is witnessing steady global growth as cases of tick-borne infections increase across North America, Europe, and Asia. With rising awareness, improved diagnostic capabilities, and growing reliance on antibiotics like doxycycline for effective management, the market is expected to expand through 2034. Below is a complete breakdown of key players, segmentation, clinical updates, and major market drivers.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/51958
1. What Is…
More Releases for Mastitis
Bovine Mastitis Market Is Booming So Rapidly | Neogen, Vetoquinol, Dechra
The "Bovine Mastitis Market" intelligence report, just published by USD Analytics, covers a micro-level study of important market niches, product offers, and sales channels. To determine market size, potential, growth trends, and competitive environment, the Bovine Mastitis Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study featured Zoetis,…
Bovine Mastitis Market to Witness Stunning Growth | Elanco, Ceva, Virbac
A new business intelligence report released by USD Analytics with title "Global Bovine Mastitis Market Report 2030 " has abilities to raise as the most significant market worldwide as it has remained playing a remarkable role in establishing progressive impacts on the universal economy. The Global Bovine Mastitis Market Report offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary…
Bovine Mastitis Market: Current Trends and Future Prospects
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031.
• CAGR: 6.3%
• Current Market Size: USD 0.54 Billion
• Forecast Growing Region: APAC
• Largest Market: North America
• Projection Time: 2021- 2031
• Base Year: 2021
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 : https://www.alliedmarketresearch.com/request-sample/17988
Bovine mastitis, an inflammatory condition of the mammary gland in dairy cows, poses…
Global Bovine Mastitis Market: Prevalence, Challenges, and Opportunities
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031.
• CAGR: 6.3%
• Current Market Size: USD 0.54 Billion
• Forecast Growing Region: APAC
• Largest Market: North America
• Projection Time: 2021- 2031
• Base Year: 2021
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 : https://www.alliedmarketresearch.com/request-sample/17988
Bovine mastitis is a prevalent and economically significant disease affecting dairy cattle worldwide.…
Emerging Therapies and Innovations in the Bovine Mastitis Market
Bovine mastitis, a common and costly disease affecting dairy cattle, continues to be a significant challenge for the dairy industry worldwide. It is characterized by inflammation of the udder tissue, leading to reduced milk production, decreased milk quality, and increased treatment costs.
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022…
Demand for Safe and Quality Milk Boosts Bovine Mastitis Market
Bovine mastitis is a common and serious disease that affects dairy cows. It is an inflammatory response of the udder tissue, caused by bacteria or other pathogens that infect the cow's mammary gland. Mastitis can cause milk production to decrease, and the milk produced can be of poor quality and even unsafe for human consumption.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐔𝐩𝐝𝐚𝐭𝐞𝐝 𝐕𝐞𝐫𝐬𝐢𝐨𝐧 2023: https://www.alliedmarketresearch.com/request-sample/17988
The bovine mastitis market was valued at…
